acetylleucyl-leucyl-norleucinal has been researched along with Parkinson Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hyman, BT; Kawamata, H; McLean, PJ | 1 |
1 other study(ies) available for acetylleucyl-leucyl-norleucinal and Parkinson Disease
Article | Year |
---|---|
Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
Topics: alpha-Synuclein; Animals; Brain; Carrier Proteins; Cerebral Cortex; Cryoprotective Agents; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dimethyl Sulfoxide; Fetus; Genes, Reporter; Green Fluorescent Proteins; Humans; Immunohistochemistry; Inclusion Bodies; Intracellular Signaling Peptides and Proteins; Leupeptins; Luminescent Proteins; Mice; Multienzyme Complexes; Nerve Tissue Proteins; Neurons; Parkinson Disease; Proteasome Endopeptidase Complex; Protein Structure, Tertiary; Recombinant Fusion Proteins; Synucleins; Tumor Cells, Cultured | 2001 |